Navidea Biopharmaceuticals Inc (NAVB)

[casperboo]

In calendar year 2014, NAVB has only traded at or above a 2.00 pps for 23 days...and one has to go way back to January, February, and March 2014 to see it. It was a whopping 2.12 (March 18th) that the stock topped out at in 2014. We only saw one insider buy of 100,000 shares when the pps was smacked under a dollar a few weeks ago. Of course, Brent Larson bought none.

CONCLUSION: Numerous rude surprises await the NAVB investor in 2015, STARTING with the Q4 report for 2014. How ridiculous for the company to issue guidance of $5-6 million for revenues in 2014 and then turn around and lower it only a few months later. Whatever they offer in guidance for 2015, their reputation is already damaged from changing the 2014 forecast.


Maybe we'll hear of another GE style loan with high interest and fees that will never by used, but can serve to drain precious capital instead! For only $4 million dollars up front in fees, the company can have a new line of credit available of $14 million. Sounds reasonavbe to me!

Maybe we'll hear of a 50,000,000 share offering at .72 to a firm like Cornell Capital.

MAJOR MANAGEMENT changes still need to be made, and AN SEC INVESTIGATION is MORE THAN CALLED FOR HERE! Mandatory layoffs are absolutely called for here. The company has one product they can't (or won't) sell...THEY DO NOT NEED 46 people to lay around with their thumbs up their behinds!

SALARY REDUCTIONS OF AT LEAST 50% FOR TULIP AND LARSON ARE A MUST, unless of course, the company is smart enough to get rid of these two outright with no severance. I can dream anyways...I'll never understand the restraint of Oldtimers at shareholder meetings and the fact that Tulip, Larson, and all other executives walk away from the meetings unharmed.